Literature DB >> 17945285

The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.

Vladimir Yutkin1, Dov Pode, Eli Pikarsky, Ofer Mandelboim.   

Abstract

PURPOSE: Up to 90% of patients with high grade superficial bladder tumors experience tumor recurrence and up to 50% have progression despite bacillus Calmette-Guerin treatment. Natural killer cells have a major role in the mechanism of the response to bacillus Calmette-Guerin but the exact mechanisms are still elusive. The recently discovered natural cytotoxicity receptors are linked to the host response to viral infection and to cancer. We tested the hypothesis that tumor expression of natural cytotoxicity receptor ligands can serve as a predictive factor for the response to intravesical bacillus Calmette-Guerin in patients with nonmuscle invasive, high grade bladder cancer.
MATERIALS AND METHODS: We developed a histochemical staining method for analysis of the ligands of the 3 known natural cytotoxicity receptors NKp30, NKp44 and NKp46 using genetically engineered fusion proteins and an automated image analysis system. We examined formalin fixed, paraffin embedded sections of specimens of transurethral bladder tumor resection from patients with primary, nonmuscle invasive, high grade bladder cancer who were subsequently treated with bacillus Calmette-Guerin. We compared natural cytotoxicity receptor ligand expression to the response to bacillus Calmette-Guerin immunotherapy.
RESULTS: Six of 17 patients (35%) had recurrence despite bacillus Calmette-Guerin treatment. Primary tumors from favorably responding patients expressed higher levels of ligands for all 3 fusion proteins (NKp30, NKp44 and NKp46 p = 0.0026, 0.027 and 0.044, respectively).
CONCLUSIONS: Bacillus Calmette-Guerin resistant, high grade, nonmuscle invasive bladder tumors express significantly lower levels of ligands of all 3 natural cytotoxicity receptors compared with bacillus Calmette-Guerin responsive tumors. This suggests that down-regulation of these ligands facilitates escape from the bacillus Calmette-Guerin effect. Furthermore, analysis of ligand expression, which can be performed on formalin fixed, paraffin embedded sections, may serve as a new predictive assay for the response to bacillus Calmette-Guerin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945285     DOI: 10.1016/j.juro.2007.07.118

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Mathematical model of tumor immunotherapy for bladder carcinoma identifies the limitations of the innate immune response.

Authors:  Romulus Breban; Aurelie Bisiaux; Claire Biot; Cyrill Rentsch; Philippe Bousso; Matthew L Albert
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

2.  Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.

Authors:  Nicolas F Delahaye; Sylvie Rusakiewicz; Isabelle Martins; Cédric Ménard; Stephan Roux; Luc Lyonnet; Pascale Paul; Matthieu Sarabi; Nathalie Chaput; Michaela Semeraro; Véronique Minard-Colin; Vichnou Poirier-Colame; Kariman Chaba; Caroline Flament; Véronique Baud; Hélène Authier; Saadia Kerdine-Römer; Marc Pallardy; Isabelle Cremer; Laetitia Peaudecerf; Bénédita Rocha; Dominique Valteau-Couanet; Javier Celis Gutierrez; Jacques A Nunès; Frédéric Commo; Sylvie Bonvalot; Nicolas Ibrahim; Philippe Terrier; Paule Opolon; Cristina Bottino; Alessandro Moretta; Jan Tavernier; Pascal Rihet; Jean-Michel Coindre; Jean-Yves Blay; Nicolas Isambert; Jean-François Emile; Eric Vivier; Axel Lecesne; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2011-05-08       Impact factor: 53.440

3.  Predictive biomarkers of bacillus calmette-guérin immunotherapy response in bladder cancer: where are we now?

Authors:  Luís Lima; Mário Dinis-Ribeiro; Adhemar Longatto-Filho; Lúcio Santos
Journal:  Adv Urol       Date:  2012-08-07

4.  Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort.

Authors:  Nicole Prada; Guillemette Antoni; Frédéric Commo; Sylvie Rusakiewicz; Michaela Semeraro; Faroudy Boufassa; Olivier Lambotte; Laurence Meyer; Marie-Lise Gougeon; Laurence Zitvogel
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

Review 5.  The structural basis of ligand recognition by natural killer cell receptors.

Authors:  M Gordon Joyce; Peter D Sun
Journal:  J Biomed Biotechnol       Date:  2011-05-18

6.  NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.

Authors:  Eva María García-Cuesta; Sheila López-Cobo; Mario Álvarez-Maestro; Gloria Esteso; Gema Romera-Cárdenas; Mercedes Rey; Robin L Cassady-Cain; Ana Linares; Alejandro Valés-Gómez; Hugh Thomson Reyburn; Luis Martínez-Piñeiro; Mar Valés-Gómez
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

7.  High SEPT9_i1 protein expression is associated with high-grade prostate cancers.

Authors:  Roni Gilad; Karen Meir; Ilan Stein; Larissa German; Eli Pikarsky; Nicola J Mabjeesh
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

Review 8.  Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Dis Markers       Date:  2015-11-23       Impact factor: 3.434

9.  High mannose level in bladder cancer enhances type 1 fimbria-mediated attachment of uropathogenic E. coli.

Authors:  Naseem Maalouf; Chamutal Gur; Vladimir Yutkin; Viviana Scaiewicz; Ofer Mandelboim; Gilad Bachrach
Journal:  Front Cell Infect Microbiol       Date:  2022-08-31       Impact factor: 6.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.